Angiotensin II type 1 receptor blocker-induced immune thrombocytopenia: a case report [PDF]
The development of thrombocytopenia after a dose increase in losartan and subsequently after switching the patient to valsartan is reported.A 61-year-old Caucasian man presented with epistaxis and gingival bleeding of three weeks duration. Laboratory evaluation revealed a hemoglobin level of 144g/L, a leukocyte count of 16.2×109 cells/L (72.51 ...
Patel, Dhiren K. +2 more
openaire +2 more sources
Advances in the Renin-Angiotensin-Aldosterone System: Relevance to Diabetic Nephropathy
Hypertension is now recognized as a key contributory factor to the development and progression of kidney disease in both type 1 and type 2 diabetes. The renin angiotensin system (RAS) and its effector molecule angiotensin II, in particular, have a range ...
Audrey Koitka, Christos Tikellis
doaj +1 more source
The angiotensin II Type 1 receptor blocker losartan in clinical practice: a review
Blockade of angiotensin II receptors was first achieved in the 1970s using a peptide, saralasin acetate. Although it was effective in lowering blood pressure, it required parenteral administration and had a short duration of action and partial agonist activity.
H P, Gavras, C M, Salerno
openaire +2 more sources
Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis [PDF]
Nonalcoholic steatohepatitis (NASH) is now the most frequent cause of chronic liver impairment in developed countries and is a suggested causative factor in the development of cryptogenic cirrhosis and hepatocellular carcinoma.
Akira, Hirose +10 more
openaire +2 more sources
Angiotensin II facilitates fibrogenic effect of TGF-β1 through enhancing the down-regulation of BAMBI caused by LPS: a new pro-fibrotic mechanism of angiotensin II. [PDF]
Angiotensin II has progressively been considered to play an important role in the development of liver fibrosis, although the mechanism isn't fully understood.
Yu-Sheng Li +6 more
doaj +1 more source
The Role of Renin–Angiotensin System in Diabetic Cardiomyopathy: A Narrative Review
Diabetic cardiomyopathy refers to myocardial dysfunction in type 2 diabetes, but without the traditional cardiovascular risk factors or overt clinical atherosclerosis and valvular disease.
João Pedro Thimotheo Batista +3 more
doaj +1 more source
Portal hypertension (PHT) resulting from splanchnic vasodilatation is a major cause of morbidity and mortality in patients with cirrhosis. The renin-angiotensin system (RAS) plays an important role in splanchnic vasodilatation in cirrhosis.
Lakmie S. Gunarathne +3 more
doaj +1 more source
Electronic sculpting of ligand-GPCR subtype selectivity:the case of angiotensin II [PDF]
GPCR subtypes possess distinct functional and pharmacological profiles, and thus development of subtype-selective ligands has immense therapeutic potential.
Pappas, Charalampos G. +41 more
core +1 more source
Olmesartan potentiates the anti-angiogenic effect of sorafenib in mice bearing Ehrlich's ascites carcinoma: role of angiotensin (1-7). [PDF]
Local renin-angiotensin systems exist in various malignant tumor tissues; this suggests that the main effector peptide, angiotensin II, could act as a key factor in tumor growth.
Mohammad M Abd-Alhaseeb +3 more
doaj +1 more source
Diminazene aceturate (DIZE) is a putative angiotensin-converting enzyme 2 (ACE2) activator and angiotensin type 1 receptor antagonist (AT1R). Its simple chemical structure possesses a negatively charged triazene segment that is homologous to the ...
John M. Matsoukas +12 more
doaj +1 more source

